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INTRODUCTION 
 
            Female genital tract is one of the most common places  for primary 
malignant disease, among that cervix is the most common site affected by 
cancer. Worldwide cervical carcinoma continuous to be a significant health 
care problem. In developing countries ,cancer cervix is the most prevalent 
cancer .It has long preinvasive course and easily preventable by early detection 
and treatment.  
         The gynecologists and primary health care providers to women are 
familiar  with vaccine programmes, screening techniques, diagnostic 
procedures, risk factors for cervical cancer and management of pre invasive 
disease. Improved patient education also contributed to improve the screening 
programmes. 
             Pre invasive lesions progress  slowly over 15-20 years to invasive 
cancer. Cervix is easily accessible to effective screening tests. It is also 
preventable  malignancy and screening tests identify the pre invasive  
neoplastic condition in  asymptomatic women. 
             Colposcopy is a study of the subtle changes in the vascular pattern of 
the cervix, while cytology is a study of morphological changes in the cell. 
Excellent visualization of the cervix and vaginal portion is essential in 
colposcopy. The transformation zone should be circumferentially visualized. 
The use of a green filter helps to enhance the visualization of vascular 
abnormalities. After application of 5% acetic acid and lugol’s iodine over the 
cervix and the abnormal areas are identified  and treated according to the 
findings.  
           The colposcopy, Pap smear, Liquid based cytology, colposcopically 
directed biopsy are the four methods by which the cervix can be studied for 
evidence of early malignant change. They are simple OPD procedures requires 
no anesthesia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
1. To compare the efficiency of COLPOSCOPIC VIA, VILI, LIQUIPREP 
TM and conventional pap smear; as screening procedure for carcinoma 
cervix. 
2. To study the correlation between cytological and histological findings 
with cervical biopsy as gold standard.  
3. To study the correlation between colposcopy and histological findings 
with cervical biopsy as gold standard. 
4. To compare the efficacy between conventional pap smear with liquid 
based cytology smear.   
5. To compare the cytological and visual inspection findings with 
colposcopic directed biopsies. 
6. To evaluate the sensitivity and specificity of colposcopy versus 
cytological study in early detection of lesions.    
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
The colposcopic procedure was developed in 1925 by German physician 
Hinselmann associated with Dr. Helmut Wirths.(1) 
 In 1928, Walter Schillar invented the Schiller’s test. He found that weak 
iodine solution would stain the glycogen in normal cervical squamous 
epithelium and result in iodine positive area with dark mahogany brown 
colour, leaving the other areas with lesions unstained.(1) 
In 1934, Sacks complained that this cumbersome equipment leads to 
failure of colposcopy 
In 1943,Papanicolaou   and Trait , Published their book on cancer 
diagnosis by vaginal smear. They discovered that precancerous and cancerous 
cells could be identified in cytologic samples from vaginal samples. This  let to 
the publication of the first book in the papsmear test in 1941.In addition to the  
collection of the cervical sample improves the sample quality.(27)  
American cancer society recognised Pap smear test as an effective  
cervical cancer screening method in 1945.(28)   
In 1947, Ayre introduced the spatula for sampling the cervix. 
 
In 1956, Hinselmann invented the video colposcopy. 
Navrratil indicated that by combination of cytologic screening with 
colposcopy, it was possible to increase the accuracy rate of early cancer 
detection by 99%. 
Richat in 1967, introduced the term cervical Intraepithelial neoplasla. In 
1967, Coppleson and Reid decribed  the colposcopic features of immature 
metaplasia.(19) 
Stafi developed colposcopic terminologies in 1970.       
British colposcopic group was formed in 1971. Coppleson, Pixely and 
Reid published their first edition of colposcopic text. It established the 
importance of transformation zone.(19) 
IFCPC standardized the colposcopic terminologies in 1975.It introduced 
the international nomenclature for colposcopic findings and it made rapid 
adoption of colposcopy world wide. 
 Evaluation of cervical lesions by the combined use of colposcopy, 
cytology and cervical biopsy by Usha saraiya and Maya Lulla in their 
Colposcopy clinic at Mumbai in 1984.It showed pick up rate of  cervical 
cancer in Colposcopy study alone was 13% in non-suspicious group. 
The incidence of cancer cervix decreased by almost 70% in the period of      
1955 – 1980 by using pap smear as a single screening method in America 
 In 1988, Duggan et al studied the natural history of CIN I lesions.(9) 
De Pale (Italy) published a manual on Colposcopy in 1990 for the treatment of 
lower genital disease. 
In 1993, Simmons, evaluated that smoking is one of the causes for 
cervical cancer and suggesting that smoking modified the DNA in cervical 
epithelial cells that leads to the development of  cervical cancer. 
In 1997, Gullota, Margarati and Rabihi studied the correlation among 
Colposcopy, cytology and biopsy in the diagnosis of precancerous lesions of 
the cervix. The Sensitivity for the detection of CIN was 70% with cytology 
sample and 92% with Colposcopy. 
In 1998, Mitchel et al studied the role of colposcopy for the diagnosis of 
CR4. He found that the sensitivity of diagnostic colposcopy with all grade 
cervical dysplasias was 96% and the specificity was 48%.(21) 
In 1988, Feinstein et al evaluated that the pre and post procedure value 
of endocervical curettage in the detection of CIN and cancer cervix. He 
concluded that routine endocervical curettage should be a part of pre operative 
assessment of an abnormal pap test but it may be unnecessary in the evaluation 
for residual dysplasia.(12)  
Olaniyan B meta analysis explained the validity of colposcopy in the 
diagnosis of precancerous lesions. He concluded that colposcopy is one of the 
valid tools for the diagnosis of precancerous lesions.(23) 
Jin h,Wan Y et al, evaluated that new cytologic screening methods  on 
preinvasive lesions.They are pap smear,liquid based cytology and computer 
technology  .They  concluded that woman ranging from 30 – 50 years should 
do cytologic screening and colposcopic examination regularly.(16) 
  Basu P.S and Sankaranarayanan et al, studied the findings of VIA  and 
VILI in cervical cancer screening. They concluded the sensitivity of VIA and 
VIAM test  were 55.7% and 60.7% respectively .(3) 
Etherington used video telecolposcopy to record the colposcopy 
findings.The findings subsequently transmitted to a specialist for interpretation. 
The sensitivity for this was 88.9% and the specificity was 93.3%.(11) 
Yarandi and colleagues studied the colposcopic and biopsy findings of 
woman with cytologic diagnosis of ASCUS. They concluded that ASCUS was 
a good indicator for detecting SIL and condyloma.(37) 
Benedict J.L did an analysis on 84,244 patients by cytology and 
colposcopy program in British Columbia .He found that colposcopy correlated 
well with cytology within one degree in 90% of cases. The cytology and 
histology correlation seen is 82%.(4) 
ACOG concluded that the conventional pap smear was responsible for 
the initial success in reducing the incidence of cancer cervix. But it had   broad 
range of sensitivity of  30 - 87% and it had more false negative rate of  14 – 
33%. 
In 2004, Camille Andy showed that the pap smear had the sensitivity of 
51% due to high false negative rates.(5) 
 In 2005,Longatto Filho A et al study showed that conventional pap 
smear had the sensitivity of 59% and specificity of 97.8%.LBC showed the 
sensitivity of 33.3% and specificity of 100%.(18) 
In 2006,Williams A R concluded that after introduction of liquid based 
cytology , unsatisfactory smear rates were reduced.Dyskaryosis rates were 
improved.This add significant benefits to colposcopy.(36) 
Donald Angstetra et al study (2009) LBC and conventional pap smear 
showed higher sensitivity for high grade lesions.The unsatisfactory rates were 
lower for LBC.(8) 
B.M.Van Hemel et al study proved that the Turbitec cytocentrifuge 
method as a good LBC method(35). 
In 2010, Pimple .S.A et al study concluded that colposcopy is the best 
screening tool for CIN detection.(25) 
In 2012, Shuchi consul et al study concluded that the combination of pap 
smear,VIA and VILI had 100% sensitivity in detecting precancerous 
lesions(32) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) 
 
DEFINITION 
CIN means disordered arrangement of abnormal cells of stratified 
squamous epithelium in all the layers,but the basement membrane is intact. 
DEVELOPMENT    
 The existence of preinvasive stage in the development of cancer cervix 
has been known Sir Johns Williams in harvein lectures in 1886. 
 In 1910, Rubin et al., described the non invasive changes at the margins of 
invasive carcinoma. He introduced the term carcinoma in situ. 
 Improvements in cytological techniques lead to the identification of early 
precursor lesions called dysplasia, a name that acknowledges the 
malignant potential of these preinvasive lesions.  
 The carcinoma in- situ lesion was treated very aggressively, where as 
dysplasias were believed to be less significant and were  treated or not 
treated colposcopic biopsy and cryosurgery. 
 The precancerous lesions have the potential to become cancer cervix after 
long duration if they not treated earlier. 
 The term CIN was introduced by Richardt in 1968. He suggested that 
displasias have the potential for progression.  
 Most of the CIN 1and some CIN 2 lesions regress spontaneously without 
treatment. Untreated high grade CIN lesions may progress to invasive 
carcinoma.  
 Proliferating metaplasia without mitotic activity should not be called 
dysplasia or CIN because it does not progress to invasive cancer.  
 Proliferating metaplasia with mitotic activity progress to invasive cancer 
and they are called as dysplasias or CIN lesions. 
TRANSFORMATION ZONE  
 The cervix has two portions, one is endocervix which is lined by columnar 
epithelium, and  the other one is ectocervix which is lined by squamous 
epithelium.  
 The junction between the epithelium is called as squamo columnar 
junction. 
 The area between the original old and new squamo columnar junction is 
called as transformation zone. 
ETIOLOGY 
CIN is most likely to start either during menarche or after pregnancy, 
because during that time metaplasia is most active. 
But after menopause  women have only little metaplasia and they have 
only minimal risk of developing CIN due to human papilloma virus infection.  
In 1995, the WHO’s International Agency for Research on Cancer 
convened consensus panel to examine the evidence implicating specific 
sexually transmitted types of HPV in the causation of cervical neoplasia.  
Extensive molecular biologic and epidemiologic research confirms 
certain HPV types are causative factors for cervical cancer in humans. 
Human papilloma virus infection is a trigger factor in origin of cancer 
cervix. 
         Some 13 types of Human papilloma virus were identified as high risk 
oncogenic viruses (types 16, 18, 31, 33 etc..).Types 16,18 are responsible for  
more than 90% of precancerous lesions and more than 70% of cancers. 
 
Human papilloma virus 16 is the most common HPV type universally 
detected with increased frequency in high-grade intraepithelial lesions and 
invasive cancers. 
HPV16 is associated with 50% of cervical squamous cell carcinoma and 
30% of adenocarcinomas. 
HPV16 infection is not very specific to cause cervical cancer in humans. 
HPV16 infection can be found in 16% of women with low grade lesions and in 
upto 14% of women with normal cytology. 
HPV 18 infection is found in 23% of women with invasive cancers, 5% 
of women with CIN2/3 5% of women with CIN1 and 2% of women with 
negative findings. So HPV 18 infection is more specific. 
 
RISK FACTORS 
I. Demographic factors  
 Older age, 
 Race (e.g Black, Hispanic, American Indian), 
 Residence in selected parts of Africa, Asia or Latin America  
 Low socio-economic status. 
 Lower education status. 
II.  Behavioral and sexual factors   
  Sexual promisquity, 
  Early sexual exposure, 
  Cigarette smokers, 
  Long term oral contraceptive use,  
 Diet low in folate, carotene, vitamin C. 
 
III. Medical/Gynecologic factors  
 Multiparity, 
 Early age at first pregnancy, 
 History of sexually transmitted disease  (especially herpes genitalis or 
HPV associated lesions) infection with specific type of HPV, 
 Lack of routine cytologic screening 
 Immunosuppression (any case). 
 
TYPES OF CIN 
1. CIN1 
 It refers to the cellular changes confined to the lower one third of the 
Epithelium. It corresponds to mild dysplasia. 
2.  CIN2 
 It refers to the cellular changes confined to the lower two thirds of the 
Epithelium. It corresponds to moderate dysplasia. 
3. CIN3 
 It refers to the cellular changes confined to the entire Epithelium. It 
includes both severe dysplasia and carcinoma in situ. 
 
CLASSIFICATION 
 
 
PROGRESSION AND REGRESSION 
Progression and regression occurs due to various factors. Progression 
occurs due to continous exposure to high risk HPV infection, low immunity 
and poor hygiene. Regression is due to host natural and acquired immunity. 
Progressive and Regressive changes in CIN lesions: 
 Most of the CIN lesions spontaneously regress without treatment. 
 Most of CIN1 lesions will regress within a year or two. Some CIN 1 
lesions will progress to cervical carcinoma in-situ and rarely progress to 
invasive cancer. 
 In CIN 2 lesions, half of them will regress within two years without 
treatment. 5% of lesions will progress to invasive carcinoma. 
 In CIN 3 lesions, progress to invasive carcinoma is more compared to 
CIN1and2.  
 
CHANGES CIN 1 (%) CIN 2 (%) CIN 3 (%) 
Regression 50 – 60 41 – 43 33 
Persistance 30 - 41 40 – 48 55 
Progression to CIN 3 10 – 19 9 – 20 Not Applicable 
Progression to 
Squamous cell 
carcinoma 
± 1 5 ≥ 12 
 
 
 
 
SCREENING 
 CIN lesions mostly have no symptoms. So it is essential for the women 
must have regular cervical screening to detect preinvasive lesion. 
 Cervical screening is a way of checking women regularly for changes in 
the cells in the cervix to identify cervical lesions in precancerous stage.  
 Invasive cervical cancer is mostly preventable if the precancerous lesions 
are detected early by effective screening methods and treated with best 
methods.  
 Several screening methods are now easily available for early detection of 
precancerous lesions.   
 The exposure to carcinogens starts from the onset of sexual activity, so 
screening starts at this time. 
 Screening methods vary from country to country and region to region. 
ACOG GUIDELINES FOR SCREENING 
 Initial screening - age 21years or 3 years after vaginal sex 
 Interval   - Every year for either liquid – based Pap  
      smear or conventional pap smear. 
Every 2-3 years after age of 30 with 3 
consecutive smears are normal. 
 Discontinue  - No upper limit of age.  
 
 
 
 
 
 VARIOUS SCREENING METHODS 
 
1 Conventional Pap smear 
2 Bimanual pelvic Examination 
3 Visual inspection of cervix after applying Lugol’s iodine ( VILI )   
4 Visual inspection of cervix after applying 5% acetic acid (VIA) 
5 Colposcopic VIA, VILI. 
6 Colposcopic directed biopsy 
7 Liquid based   cytology 
8 Automated cervical screening techniques 
9 Neuromedical system 
10 HPV DNA testing 
11 Polar probe test 
12 Laser induced fluorescence 
13 Speculoscopy 
14 Cervicography 
 
 
 
 
 
 
COLPOSCOPY 
 Colposcopy is one of the medical diagnostic procedures to examine the 
cervix vulva, vagina under high magnification and bright illumination. 
 It is used to detect precancerous and cancerous lesions of cervix, vagina, 
and vulva. 
 Whenever cervical screening test is positive, irrespective of the method 
used or when the patient complaints of post coital bleeding, persistent 
vaginal discharge next most important step is colposcopy. 
  KOLPOS-vagina, SKOPOS-look at. 
AIMS OF COLPOSCOPY 
1. To determine the position of Transformation Zone 
2. To confirm or refuse the suspicious of cervical intra epithelial lesion. 
3. To recognize or rule out invasive cancer or glandular disease of the 
cervix. 
4. To facilitate treatment. 
5. Monitor progressive or regressive changes of cervical intra epithelial 
lesions1, 2. 
6. Follow up of treatment procedures like cryotherapy, LLETZ, other 
ablative and excisional procedures. 
 
PROCEDURE 
 The most important part of the colposcopic examination is identifying 
the transformation zone and identifying normal and abnormal areas. 
 The procedure must be explained and informed to the patient and 
consent to be obtained. 
 Insert the bivalve cusco’s speculum and examine the cervix – after 
exposing the cervix, assess the secretion of the cervix, the obvious 
examination findings like ectopy, nabothian follicle, condyloma, ulcer 
etc., are noted. 
 First apply normal saline either with the spray or with soaked cotton ball 
and remove the excess mucus and discharge. 
 Then identify the proximal and distal borders of the transformation zone.  
 Then use green filter and examine the blood vessel patterns 
 The new squamo columnar junction may be seen using a Q-Tip 
applicator and try to see the anterior of posterior lip that helps  to 
visualize the Squamo-columnar junction. 
 An endocervical speculum or the tips of the long dissection forceps is 
used to visualize the Squamo-columnar junction.If the squamo-columnar 
junction is not seen entirely,it is called as  “Unsatisfactory” colposcopy. 
 The distal limit of the transformation zone namely the original  old 
squamo-columnar junction is identified by finding the most distal crypt 
opening or nabothian follicles in the lips of cervix and drawing an 
imaginary line connecting these land marks. 
 Applying 3 to 5% acetic acid: Then 3 to 5% acetic acid is applied and 
the appearances of acetowhite areas are noted. The areas where there is 
increased keratin and nuclear protein, example immature squamous 
metaplasia, inflammation, condyloma, precancerous areas pick up acetic 
acid. Abnormal areas pickup the acetic acid faster and retains it for a 
longer time. The acetowhite is denser in precancerous and cancerous 
areas. In immature squamous metaplasia it is less pale, thin and often 
translucent and with illdefined borders. 
  Applying Lugol’s Iodine: Normal squamous epithelium stains 
mahogany brown with Lugol’s Iodine due to glycogen .The coloumnar 
epithelium does not contain glycogen and does not stain with iodine. 
Likewise immature squamous metaplasia, inflammatory epithelium and 
congenital transformation zone do not contain glycogen and do not or 
partially stained with Iodine. 
 The next step is to integrate the findings of saline, acetic acid and Iodine 
test to make an assessment. IFCPC nomenclature and swede scoring 
systems are used for interpretation. 
 Take biopsy if necessary 
 Inspect the vaginal walls, vulva and perineum when the speculum is 
withdrawn. 
 Interpret the findings. 
 INTERPRETATION 
First step in colposcopy is complete visualization of new Squamo-columnar 
junction and when new Squamo-columnar junction is not fully visible the 
examination is judged unsatisfactory. 
1. Normal colposcopic findings. 
2. Abnormal colposcopic findings. 
3. Colposcopic findings suggestive of invasive cancer. 
4. Unsatisfactory colposcopy. 
5. Other findings like, 
a) Condylomata, 
b) Keratosis, 
c) Ectopy, 
d) Inflammation, 
e) Trophy, 
f) Deciduosis of pregnancy, 
g)  Polyps. 
IFCPC  
Accepted in Rio world congress, July 5, 2011 
Nomenclature committee chairman Jacob Borstein MD 
                                      2011 IFCPC  colposcopic terminology of the cervix 
General assessment 
 Adequate/inadequate for the reason - (i.e., cervix 
obscured by inflammation, bleeding, scar ) 
 Squamo-columnar junction visibility completely 
visible, partially visible, not visible. 
 Transformation zone type 1, 2, and 3. 
Normal colposcopic 
findings 
Original squamous epithelium: 
 Mature 
 Atrophic 
Columnar epithelium: 
 Ectopy 
Metaplastic squamous epithelium: 
 Nabothian cysts. 
 Crypt ( gland ) openings 
Deciduosis in pregnancy.  
Abnormal 
colposcopic 
findings 
General  
Principle 
Location of the lesion: Inside or outside the T – zone 
Location of the lesion by clock position. 
Size of the lesion: Number of cervical quadrants the 
lesions covers, 
Size of the lesion in percentage of cervix. 
 
Grade 1 
( Minor) 
Thin aceto-white 
epithelium  
Irregular, geographic 
border 
Fine mosaic 
Fine punctuation. 
 
 
Grade 2 
( Major) 
Dense aceto-white 
epithelium, 
Rapid appearance of  
aceto-whitening, 
 Cuffed crypt (gland) 
openings  
Coarse mosaic, 
Coarse punctuation, 
Sharp border, 
Inner border sign, 
Ridge sign.  
 
Non 
Specific 
Leukoplakia (keratosis, hyperkeratosis), erosion. 
Lugol’s staining (Schiller’s test) Stained/Non-
stained. 
Suspicious for invasion  
Atypical vessels. 
Additional signs: Fragile vessels,Irregular 
surfaces,Exophytic lesion,Necrosis,Ulceration  
( necrotic ), tumor/gross neoplasm. 
Miscellaneous findings  Congenital transformation Stenosis, 
zone 
Condyloma 
Polyp ( Ectocervical ) 
Endocervical 
Inflammation. 
Congenital anomaly, 
Post treatment 
consequences, 
Endometriosis. 
  
  
 
 
SWEDE SCORING SYSTEM 
 
SCORE 0 1 3 
ACETO 
UPTAKE 
0 or Transparent Thin, milky Distinct, stearin 
MARGINS 0 or diffuse 
Sharp but irregular 
Jagged, satellites 
Sharp & even 
Difference in level 
VESSELS Fine, regular 0 
Coarse or atypical 
Vessels 
 
LESIONS 
SIZE 
 
< 5 mm 
5-15 mm or 2 
Quadrant 
>15mm,3-4 
quadrants 
or endocervically 
Undefined. 
IODINE 
UPTAKE 
Brown 
Faintly or patchy 
Yellow 
Distinctly yellow 
A total score < 5 or 0 for aceto or margins excluded high grade lesion. 
 
DIFFICULT SITUATIONS IN COLPOSCOPY 
Infections of the cervix and vagina are very common in the reproductive 
age group and cause many problems and it also obscures the colposcopic 
features of the transformation zone. 
1. There is sloughing of the superficial epithelium resulting in red blotches 
and resemble preinvasive lesion.   
2. Acetowhite areas sometimes may not be as obvious due to thickening of 
the superficial epithelium and sloughing of the epithelium.  
3. The tissue is easily traumatized during examination and may bleed. 
4. Basal layers of the epithelium are not well glycogenated, so there is 
patchy up take of iodine resulting in a leopard skin appearance due to 
infection. 
5. Recurrent ulceration and healing by fibrosis can result in distortion of 
the cervix and misinterpretation of findings. 
6. Specific infections like herpes can produce large coalesced ulcer that  
look like invasive cancer. 
 
DIFFERENCE BETWEEN INFLAMATION AND CIN 
1. Usually infections are symptomatic and precancerous lesions mostly 
asymtomatic. 
2. The changes are spread diffusely over the cervix and not strictly 
confined to the transformation zone. 
3. Inflammatory punctuations are fine with minimal inner capillary 
distance and possible extension to the vagina. 
ADVANTAGES 
 This test is exactly localize the lesion. 
 It evaluates the extension of lesion. 
 It differentiates inflammatory and cancer lesions. 
 It differentiates invasive and non invasive cancer lesions. 
 Follow up is easy. 
DISADVANTAGES 
 Unable to detect endocervical lesion.  
 Needs more training and experience. 
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 PAP SMEAR 
DEFINITION 
Pap smear is a cytological screening test used to detect precancer and 
cancer lesions in the cervix Transformation zone. Pap smear was invented by 
Greek doctor Georgios Papanicolaou. 
The pap smear test has been used since 1950 as a screening test and 
effectively reduced the  incidence. 
INDICATIONS 
Screening  guidelines for Pap smear vary from country to country. 
Screening starts at 20years or 25years and continues until 60years of age. 
Screening is typically recommended every three to five years if previous 
Pap smear results are normal. 
If age 65years with previous history of normal pap tests no further tests 
are needed. 
TYPES 
(i) Conventional Pap smear. 
(ii) Liquid based cytology. 
PREPARTION METHOD OF CONVENTIONAL PAPSMEAR 
Cusco’s bivalve speculum is used to open the vaginal wall and allows 
access to the cervix.  
The ectocervix is scraped circumferentially using a spatula. The 
cytobrush is recommended for sampling the endocervical cells. Endocervical 
brush produces highest yield of endocervical cells. Both these samples best 
represent the cervical disease status.  
Women planning to have a pap test for cervical cancer are advised to 
avoid the test during their menstrual period .They are advised to avoid 
douching, sexual intercourse,  putting tampons or medications into the vagina 
for 48 hours prior to the screening test. 
The basis for these recommendations is to obtain the most representative 
cellular sample and to avoid false negative samples. 
Both douching and tampons use are risk factors for removing the most 
superficial cells, that represent the area where a  precancerous lesion is most 
likely to occur. 
Ectocervix samples are obtained before endocervical samples to reduce 
the effect of bleeding from the endocervix. 
PROCEDURE 
 The patient is placed in dorsal position and adequate light source is used 
to visualize vagina and cervix. 
 A cusco's bivalve speculum is used to expose the cervix. No lubricant 
should be used on the bivalve speculum.  
 Ayre's spatula is placed over the ectocervix with the longer protrusion in 
the cervical canal and rotates the spatula for 360 degree over the 
ectocervix. This would help in scraping the cells from the entire 
transformation zone. 
 If it appears to be inadequate, the spatula must be rotated for several 
times. 
 The sample cells from the spatula are placed onto the glass slide by 
rotating the spatula against the glass slide in a clockwise manner. 
 Next, an endocervical brush is placed inside the endocervix and rotated 
firmly against the canal and an endocervical sample is taken, which is 
placed on the same slide. 
 The slide is immediately fixed to avoid air-drying using 95% ethyl 
alcohol and send the slides to pathology laboratory. 
 
RISK FOR ABNORMAL PAP SMEAR 
 Women who begin sexual activity before age of 18, 
 Women who have history of multiple sexual partners, 
 Women who have repeated sexually transmitted diseases, 
 Women who have smoking habits, 
 Women who become pregnant before age of 18. 
 
 
ADVANTAGES 
 It is  cost effective and also inexpensive 
 It is ideal for mass screening. 
 It can be done by para medical staff. 
 It is also used for detection of endocervical lesion. 
 It is also used for detection of adenocarcinoma. 
DISADVANTAGES 
 It has low sensitivity 
 The value of single test is limited. 
 It cannot localize the lesion.  
LIQUID BASED CYTOLOGY PAP SMEAR 
Liquid based, thin layer cytotechnology was developed to address the 
limitation of pap smear. LBC is used to improve the specimen accuracy of Pap 
smear. 
METHODOLOGY 
Thin prep method: 
 Thin prep (cytyc) samples are collected from the cervix by using special 
cervical cytobrush, a broom like device.  
 The device is inserted over the endocervical canal until the shorter 
bristles contact the ectocervix. 
 It is rotated over the cervix five times in one direction to obtain the 
sample. 
 The cytobrush is removed from the cervix. Decap the broom and then 
put it in to the bottom of the vial that contains preservative solution. 
 In the preservative solution, the bristles are spread apart and release the 
sample. Finally the broom is swirled vigorously to further release 
material to the preservative solution and then the broom is discarded.    
LABORATORY PROCEDURE 
 The vials are placed on the thin prep processor machines, and a hollow 
cylinder with a 20 mm diameter filter bonded to its lower surface is 
inserted into the vial. 
 After a rotatory motion to disperse loose cell clusters and mucin, a 
vacuum is applied to the cylinder and cells are trapped on to the filter.  
 The cylinder is then inverted 180 degrees and the filter is gently pressed 
onto glass slide, which transfer the cells from filter to slide.  
 The slide is then fixed and stained. This techniques result in a monolayer 
of cells on the slide, which can be read more quickly than conventional 
cytology.  
 Liquid based cytology is less likely to be affected by blood than 
conventional Pap smear, but should not be recommended to obtain it 
during menstruation. 
ADVANTAGES 
 It removes mucus, blood and other specimen contamination. 
 LBC method transfers 80-90% of cells to the slide as compared to 10-
20% with conventional tests. 
 Cells are distributed uniformly. 
 This method improves fixation. 
 Preserves cellular architecture. 
 It has shorter screening time.  
 It has lower unsatisfactory rate. 
 Greater sensitivity for CIN lesions. 
 Automation. 
 Increased diagnosis of ASCUS & LSIL.  
DISADVANTAGES  
 Cost of transport vials, equipments and processing is more 
 Less specificity 
 Reduced reporting of invasive carcinoma 
 
 
 
COMPARISON OF PAPANICOLAOU, WHO AND BETHESDA 
SYSTEM 
 
Papanicolaou WHO system Bethesda System 
Class I Normal Within normal limits 
Class II Atypical 
Benign cellular changes or Atypical squamous cells of 
undetermined significance 
Class III 
Dysplasia 
Mild dysplasia 
Moderate dysplasia 
Severe dysplasia 
Squamous epithelial cell abnormality 
Low Grade squamous intra epithelial lesions (SIL) 
High grade SIL 
High grade SIL 
Class IV Carcinoma in situ High grade SIL 
Class V 
Invasive squamous cell 
carcinoma 
Adeno carcinoma 
Squamous cell carcinoma 
 
Adenocarcinoma 
 
MANGEMENT OF CIN LESION ACCORDING TO PAP SMEAR 
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 AUTOMATED SCREENING TECHNOLOGY 
 Automated screening techniques perform quality control rescreening. 
 This method is used for primary screening of cervical smears. 
 The Auto pap 300 and PAPNET (Neuromedical systems) are the two 
methods available for cervical screening. 
 These methods depend on neural  network technology are  used for 
identification of abnormal cervical cells.  
 The Autopap 300 method is approved by the USFDA for primary and 
secondary cervical screening.  
 The PAPNET is approved for secondary screening.  
 
                      BIMANUAL PELVIC EXAMINATION 
 It includes inspection of external genitalia and insert speculum and 
examine the vagina and cervix. 
 Feel the cervix, uterus and adnexa with gloved fingers and put the other 
hand over the lower abdomen. 
  
 
 
HPV-DNA TESTING 
 HPV-DNA testing using hybrid capture2 is the most sensitive test.It is 
superior to either cytology smear or colposcopic examination.  
 In new algorithm HPV-DNA test is a primary screening test. 
  It had higher sensitivity and specificity than others. 
 PCR assay is the commonest test. 
 It is helpful to women more than 30 years of age. 
 It is also used for ASCUS evaluation. 
 In high and medium resource  settings after this test only pap and LBC 
done. 
VIA (Visual inspection of the cervix with acetic acid) 
 This method is simple and easy to perform 
 It is freely available in all government settings. 
 It is done by paramedical staff in health camps, outpatient clinics etc. 
 It is done by visualization of the cervix after applying acetic acid. 
 Cervix is inspected after 2 minutes. 
 Lesions which stain acetowhite are positive. Unstained areas are called 
as negative. 
 Dull white, semi transparent areas are low grade VIA. 
 Dense or oyster whites with sharp borders are high grade VIA. 
 Positive cases are reffered to higher centres for expert opinion, follow up 
and treatment. 
 VILI (Visual Inspection with Lugol’s Iodine) 
 
 VILI is one of the visual method to screen the cancer cervix in low 
resource settings. 
 This method is also simple and easy to perform. 
 It is freely available in all government settings. 
 It is done by paramedical staff in health camps, outpatient clinics etc. 
 It is done by visualization of the cervix after applying 50% lugol’s 
iodine solution. 
 Cervix is inspected after application. 
 Normal vaginal and cervical squamous epithelium contain glycogen and 
stains as mahogany brown. 
 Normal columnar epithelium, immature and abnormal epithelium have 
no glycogen not stained by iodine solution and appeared as mustard 
yellow. 
 Positive cases are reffered to higher centres for expert opinion,follow up 
and treatment. 
 
 
 
 
SPECULOSCOPY 
 This is also one of the screening method   
 Inspection of the cervix after the application of 5% acetic acid . 
 Examine the cervix with chemiluminiscent light .  
 Low power magnification is used. 
 It is not used routinely . 
CERVICOGRAPHY 
 First  bimanual pelvic examination and Pap smear collection are done 
routinely. 
 Acetic acid is applied to the cervix. 
 It  involves taking photographs of the cervix using a special camera . 
 The photographs are then developed. 
 The slide is projected on a 2X2 meter screen.  
 It is read by an expert in colposcopy. 
POLAR PROBE 
 It is one of the screening methods. 
 This technology is based upon the fact that the tissue impedance to 
electrical simulation differs between normal and abnormal tissues.  
 The investigators have tried to utilize spectral and electrical stimulation 
of the cervical tissues.  
 It is  used as an adjunct to conventional Pap smear testing. 
 
LASER INDUCED FLUORESCENCE 
 It is used as a screening procedure. 
 Low power laser illumination can induce endogenous tissue 
fluorescence. This depends upon the chemical and morphological 
composition of individual tissues of the patient. 
 The spectroscopic difference is used to differentiate normal tissues.  
 
                               
 
 
 
                                   COMPUTER IMAGING 
 The diagnosis of precancerous changes is primarily a task of visual 
discrimination and sorting of graphical information. 
 A lot of focus on the use of computers to assist this process.  
 This is very similar to cervico-graphic techniques . 
 In this technique the computer replaces the colposcopy expert. 
   
COLPOSCOPIC DIRECTED BIOPSY 
 
 It is the best method for detecting cervical cancer and precancerous 
lesions. 
 Cervix is  first examined with colposcopy and abnormal areas  are 
localized.   
 The abnormal areas are biopsied by using cervical punch biopsy forceps. 
 This is confirmatory method and gold standard. 
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CIN 1    CIN 2 
PREVENTION 
VACCINATION 
 HPV infection is necessary for the development of cervical cancer, the 
primary was the development of a prophylactic vaccine to protect against 
HPV infection.  
 The development of a prophylactic vaccination became possible through 
the development of protein mimics that simulate the outer most protein 
capsid of the virus ie virus like particles (VLP).   
 Gardasil is a quadrivalent vaccine containing the VLPs for HPV 
6,11,16,18 was approved by the USFDA in 2006.  
 Cervarix is a bivalent vaccine contains VLPs for 16, 18 were approved in 
2009.  
 Both bivalent and quadrivalent vaccines are highly effective in preventing 
CIN2, CIN3, adenocarcinoma in situ caused by HPV16,18in women from 
15-26 of years age.  
 The women who are sero-negative and HPV DNA negative for HPV16 
and 18 at vaccination and received all the three vaccinations the efficacy 
is 100%. This protection is documented to last as long as 6.4 years after 
vaccination.  
 HPV 6, 11 infections that cause genital warts is prevented by quadrivalent 
vaccine. 
 Routine HPV vaccination is recommended for female children at 11 to 12 
years of age, but it may be provided as early as 9 years and as latest as 18 
years.  
 Screening practices for cervical intra epithelial neoplasia and cancer 
should remain unchanged in both vaccinated and unvaccinated women. 
CONDOM USE 
 
ABSTINENCE 
                                            
 
 
TREATMENT OF CIN 
 The diagnosis of cervical intraepithelial neoplasia  is confirmed  before  
starting the treatment. In many developing countries  the  treatment is 
offered at the first colposcopic clinic visit. 
 In ASCUS group 
o Three methods used: Colposcopy, HPV-DNA testing and     repeat 
cytology 
o If HPV - DNA is negative repeat cytology after 12 months. 
o If HPV-DNA is positive for high risk type, immediate colposcopy 
is done. 
o If colposcopy showed CIN lesion or cancer treat the patient as per 
guidelines. 
 In ASC-H group  
o Colposcopy is done immediately . If colposcopic examination 
shows CIN lesion or cancer treat the patient as per guidelines. 
o If colposcopic examination shows negative findings, repeated 
cytology is done at 6 & 12 months. 
 In LSIL group 
o Immediate colposcopic examination is done.  
o If colposcopy showed CIN lesions or cancer treat the patient as per 
guidelines. 
o If colposcopy showed no lesion, cytology is done at 6 & 12 months 
or HPV-DNA testing done at 12 months. 
 In HSIL group 
o Women with HSIL have significant risk of CIN 2, 3 and invasive 
cancer. 
o Immediate colposcopic examination is done.  
o Complete review of the cytology and biopsies are taken. 
o If the results are unchanged, the patient should undergo excisional 
method of treatment. 
o Women with unsatisfactory colposcopy also undergo excisional 
method of treatment.  
 Normal colposcopy findings 
They are advised to undergo repeat screening examination after 3-5 
years. 
 
 
 Reproductive tract infection 
The women with reproductive tract infections should be treated 
according to WHO guidelines. 
 Leukoplakia 
In leukoplakia ,the area should be biopsied and submitted for HPE to 
rule out cervical cancer and treat according to the HPE findings. 
 Condyloma 
In condylomata , the area should be biopsied and localized ectocervical 
exophytic lesions may be treated with either  ablative method  or 
excisional method of treatment. 
 In CIN1 lesions, 
o Most CIN1 lesions are  regressed spontaneously without treatment. 
o Repeat cytology at 6 & 12 months or HPV-DNA testing at 12 
months are done. 
o Follow-up with colposcopy and cytology at 12 months are done. 
o If the lesions persist or progress diagnostic excisional treatment is 
done.  
o Non complaint patients should have immediate treatment.  
 
 
 In CIN 2/3 lesions, 
o The risk of persistence and progress to invasive cancer is more in 
CIN 2/3 lesions. 
o In CIN 2/3 lesions immediate treatment with excisional method of 
treatment. 
o In excisional treatment, if the margins have lesions then follow-up 
with colposcopy and endocervical curettage. 
o If follow-up shows persistence and patient completed the family 
hysterectomy is the best option.  
INVASIVE CANCER 
o A diagnosis of invasive squamous cell carcinoma or adenocarcinoma may 
be found during examination. 
o It requires prompt referral for definitive treatment with either surgery or 
radio therapy, with or without chemotherapy. 
METHODS OF TREATMENT 
 ABLATIVE METHODS 
Eradication of abnormal epithelium and prevent its recurrence with least 
morbidity. This method includes cryosurgery, electrocoagulation 
diathermy and CO2 laser ablation. 
 EXCISIONAL METHODS  
The excision of the transformation zone treats the abnormality and 
specimen is available for HPE. They are LLETZ, cold-knife conization, 
CO2 laser excision, NETZ and hysterectomy. 
 CRYOSURGERY 
o It is an ablative procedure and an optimal treatment for benign 
epithelial abnormalities of the cervix. 
o It destroys precancerous tissue through cryonecrosis.  
o Safe method of treatment with no significant morbidity or mortality 
risks.  
o A rapid freeze followed by a slow thaw is the most damaging to 
cells especially neoplastic cells. A sequence of two freeze-thaw 
cycles (freeze-thaw-freeze-thaw) may produce more tissue 
destruction than a single cycle (freeze for 3 minutes and thaw for 5 
minutes) 
o It is the destructive procedure which draws heat from the tissue in 
contact with the cryoprobes through which a freezing agent, N2O (-
89C) or CO2 (-68C), is circulated converting the tissue into an 
iceball through ice ball cryoprobes. 
o No sample is obtained for HPE. 
 Eligibility criteria  
o CIN is confirmed by cervical biopsy/colposcopy. 
o Entire lesion – located in the ectocervix without extension to the 
vagina or endocervix. 
o Lesion can be covered by the largest available cryotherapy probe  
(2.5 cm). 
o No evidence of invasive cancer. 
o Women should not be pregnant. 
o If recently delivered, women should be in atleast 3 months post-
partum: 
 No evidence of PID. 
 No sample is obtained for HPE. 
 
ELECTROCAUTERY 
 It is one of the oldest ablative method. 
 The depth of destruction is only 2 to 3 mm. 
 Residual lesion always present after treatment. 
 No tissue is available for HPE after treatment. 
 
 
ELECTRO-COAGULATION DIATHERMY 
 This method includes deep coagulation of cervical stroma with needle 
electrodes and destruction with ball electrodes. It is one of the ablative 
methods. 
 Healing occurs in 4 weeks. 
 
CO2 LASER VAPORIZATION 
 This method uses high intensity beam produces tissue vaporization and 
boiling of intracellular water and explosion of cell. 
 Incineration of protein and mineral and charring of the treated area. 
 Depth of tissue destruction is 6-7mm. 
 Rapid healing occurs with minimal fibrosis. 
               LLETZ (Large Loop Excision of Transformation Zone)  
 It is the most commonly used excisional method of treatment.  
 It offers more than 95% of cure rate and is a simple and safe procedure.  
 It can be done as an out-patient method of treatment. 
 It is done under local anesthesia. It is done in the large majority of CIN 
lesions. 
 It is the procedure of choice in CIN 2/3 lesions with satisfactory 
colposcopy. 
 
 
 Method 
o Radio frequency electric current is used for a large loop excision of 
the transformation zone. 
o It can be done with colposcopic guidance. 
o Different sizes of loops are available depend upon the site and size 
of the lesion. 
o Usually the specimen is removed in a single pass, sometimes it 
needs multiple passes. 
  Advantages 
o Specimen is available for histopathological examination. 
o It can be done as an out-patient method of treatment. 
o It is done under local anesthesia. 
 Complications 
o Intra and post operative haemorrhage. 
o Cervical stenosis after the procedure. 
o Increased pre term delivery and PPROM (due to deep excisions). 
 Follow-up 
o Avoid vaginal douches, tampons and coitus for one month. 
o Profuse and sometimes blood stained discharge may persist for two 
weeks. 
o Follow-up at one year with colposcopy. 
o If the lesions persist, biopsies are taken. 
o Repeat LLETZ can be done if lesions persist.   
 
 
 
NEEDLE EXCISION OF THE TRANSFORMATION ZONE    (NETZ) 
 It was invented in an attempt to combine the ease of loop excision with 
the surgical accuracy of cold knife conisation. 
 A needle electrode is used for the procedure. 
 It is one of the excisional methods of treatment.  
COLD KNIFE CONE BIOPSY 
 It is used for micro invasive cancer where evaluation of margin is 
important. 
 It is done under local anesthesia. 
 The incision should be made posteriorly and then carried anteriorly.  
 The depth of destruction is 15-20mm.  
 If cone margin is +ve - 22% residual lesion is present. 
 If cone margin is –ve - 4% residual lesion is present. 
 The complications are haemorrhage, sepsis, infertility and stenosis. 
HYSTERECTOMY 
This procedure includes Removal of uterus with cervix 
INDICATIONS 
 Associated with other gynecological Conditions. 
 Persistent Abnormal pap Smear Following Excision or Ablative 
Procedure. 
 Positive Endocervical margin after Conisation treatment. 
 
 
 
 
MATERIALS AND METHODS 
 
A study was conducted in the Dept of Obstretics and Gynaecology at 
Institue of Social Obstretics and Government Kasthurba Gandhi Hospital, 
Triplicane, Chennai-5 during the year 2011-2012. 
This study was conducted in 100 women, who fulfilled the selection 
criteria. The average number of women attending ISO & KGH was about 100 
to 150 per day in Gynecology clinic. 
Among them women who fulfilled the selection criteria were randomly 
selected. 
INCLUSION CRITERIA 
 All women in the reproductive age group. 
EXCLUSION CRITERIA 
 Pregnancy, 
 History of Hysterectomy, 
 History of cervical treatment for CIN, 
 IUCD user, 
 Sexual Intercourse with spermicidal jelly, douches/tampons 24hrs prior 
to pap smear examination. 
MATERIALS 
1. Colposcope: It is the simple colposcope with magnifications  of 5X, 10X 
and 20X with inbuilt green filter was used. The magnification can be 
altered by changing the power of the eyepieces. 
The magnifications of 7.5X - 10X were preferred which was excellent for 
localizing or zooming in the area of interest and for examining the 
vascular architecture. The best focal distance was between 250 mm and 
300mm. This allowed easy working and manipulation of instruments 
without hampering the vision 
2. Basic colposcope tray containing 
 Cotton swabs with small cotton tipped applicators, 
 5ml syringes for spraying, 
 Cusco’s  bivalve speculum, 
 Normal saline(0.9% NaCl), 
  Freshly prepared 5% acetic acid, 
 Lugol’s Iodine, 
 Ayre’s spatula with endocervical brush, 
 Cervical cytobrush, 
 Liquid prep preservative solution, 
 Glass slide,  
 95% ethanol solution in pap smear jar, 
 Cervical punch biopsy forceps, 
 10% formalin for biopsy, 
 Monsel’s solution, 
3. Light microscope 
Methods - Basic steps of examination include 
 Written informed consent and counseling regarding the procedure 
 History taking 
 Physical examination in general 
 Local examination of vulva and perenium 
 Speculum examination of cervix and vagina without cream 
 Pap smear, LBC - By using  cervical cytobrush, both smears  are taken 
 Normal saline Colposcopy 
 Examination through green filter. 
 Freshly prepared 5% acetic acid is applied over the cervix. 
 Staining the cervix with Lugol’s iodine 
 Colposcopic directed biopsy using a cervical punch biopsy forceps 
 Application of  Monsel’s paste for hemostasis. 
 Interpret the findings using IFCPC nomenclature. 
 Patient was positioned in the dorsal lithotomy position. 
 Cusco’s Bivalve speculum was introduced without use of any lubricant. 
 A cervical smear was taken with cytobrush placed in os and rotate it 5 
times over squamo columnar junction and spread on a glass slide then fixed 
immediately in 95% Alcohol, then decap the brush and put it into the thin prep 
preservative solution and sent for cytological analysis. 
 
4. Colposcopic examination of unstained cervix 
 Cervix was examined under good illumination after cleaning the vagina 
and cervix with cotton swabs dipped in normal saline in order to remove 
the discharge. 
5. Inspection with green filter 
 Vascular pattern of cervix appeared in green background when visualized 
through green filter. 
6. Inspection of cervix after 5% acetic acid application 
 Acetic acid is a mucolytic; After application, changes the colour of cervix 
after an   interval of 10-30 secs. The effect was transitory and faded away 
in 30-40 seconds. Repeated applications were required throughout the 
procedure. The   speed with which the colour appeared and the speed with 
which it   disappeared was indicative of the degree of underlying lesion. 
Low   grade CIN lesions showed a shiny white, translucent appearance, 
whereas High grade usually appeared opaque or oyster white. The whole 
transformation zone must be visualized Surface contour, margin of lesion 
and appearance of blood vessels are noted. 
7. Lugol’s iodine application 
 Cervix was painted with Lugol’s iodine in a 50% dilution. Mahogany 
Brown staining occur in glycogen rich squamous epithelium.The  
acetowhite  area  which was stained brown should indicate mature 
metaplastic epithelium. Mustard yellow or Saffron yellow indicates 
abnormal lesion. Interpretation of colposcopic findings was done by 
IFCPC nomenclature and SWEDE Scoring System. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANALYSIS AND RESULTS 
Interpretation of P value 
 
1. If P value is 0.000 to 0.010 then denoted by  **   => Significant at 1 % level 
2. If P value is 0.011 to 0.050 then denoted by  *    => Significant at 5 % level 
3. If P value is above 0.05 then denote do not put any star or NS => Not Significant at 5 
% level 
If the P value is .000 then put <0.001** 
AGE GROUP   Table: 1 
Age group in years 
Biopsy 
Total 
Significance 
(P) CIN Cervicitis 
 
20-29 
 
 
Count 7 10 17 
 
0.633 
% within Age Group in 
years 
41.2% 58.8% 100.0% 
% within Biopsy 13.7% 20.4% 17.0% 
30-39 
 
 
Count 32 27 59 
% within Age Group in 
years 
54.2% 45.8% 100.0% 
% within Biopsy 62.7% 55.1% 59.0% 
40-45 
 
 
Count 12 12 24 
% within Age Group in 
years 
50.0% 50.0% 100.0% 
% within Biopsy 23.5% 24.5% 24.0% 
Total 
Count 51 49 100 
% within Age Group in 
years 
51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
Among 100 women, 7 were between 20-29 age group , 32 cases were between 
30-39 years and 12 were between 40 to 45 years 
Incidence of CIN was 13.7% in 20-29 years age group, 62.7% in 30-39 years 
age group, 12% in 40 - 45 years age group. 
Incidence of CIN was increased in increasing age group.  In this study more 
cases were belongs to 30 – 45 years age group. 
 
 
 
 
 
 
Figure: 1 
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Cervicitis 
AGE AT MARRIAGE 
Table: 2 
 
 
Age at marriage 
 
Biopsy 
Total 
 
 
Significan
t(P) 
CIN Cervicitis 
 
 
Upto 19 
 
 
Count 42 32 74 
 
 
 
 
 
 
0.043 
% within Age at marriage 56.8% 43.2% 100.0% 
% within Biopsy 82.4% 65.3% 74.0% 
 
 
20 and 
above 
 
Count 9 17 26 
% within Age at marriage 34.6% 65.4% 100.0% 
% within Biopsy 17.6% 34.7% 26.0% 
 
Total 
 
 
Count 51 49 100 
% within Age at marriage 51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
Among 100 women ,74% were married before 19 years and 26 %   were 
married after 20 years. 
 
Incidence increased in early marriage  
 
In this study incidence of CIN was 82.4% in less than 19 years age group and 
17.6% in more than 20 years age group. 
 
In this study also incidence of CIN is increased in early marriage. 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
Figure: 2 
Age at Marriage 
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DURATION OF MARRIAGE 
Table: 3 
Duration of marriage in years 
Biopsy 
Total 
Significant
(P) CIN Cervicitis 
Below 5 
Count 0 1 1 
0.443 
% within Duration of 
marriage in years 
.0% 100.0% 100.0% 
% within Biopsy .0% 2.0% 1.0% 
6-10 
Count 5 9 14 
% within Duration of 
marriage in years 
35.7% 64.3% 100.0% 
% within Biopsy 9.8% 18.4% 14.0% 
11-15 
Count 15 13 28 
% within Duration of 
marriage in years 
53.6% 46.4% 100.0% 
% within Biopsy 29.4% 26.5% 28.0% 
Above 15 
Count 31 26 57 
% within Duration of 
marriage in years 
54.4% 45.6% 100.0% 
% within Biopsy 60.8% 53.1% 57.0% 
Total 
Count 51 49 100 
% within Duration of 
marriage in years 
51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
Among 100 women, 1% belongs to below 5 years duration of marriage, 14% 
belongs to 6 – 10 years duration , 28% belongs to 11 – 15 years and 57% 
belongs to more than 15 years duration. Incidence increased in long duration of 
sexual exposure. 
 In this study CIN lesions 9.8% belongs to 6 – 10 years duration and 29.4% 
belongs to 11 – 15 years duration and 60.8% belongs to more than 15 years of 
duration.  
 
 
 
 
  
 
 
 
 
 
Figure: 3 
Duration of marriage 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
SOCIO-ECONOMIC STATUS 
Table: 4 
Socio-economic status 
Biopsy Total 
Significant(P) 
CIN Cervicitis  
Class 3 
Count 2 31 33 
0.000 
% within SES 6.1% 93.9% 100.0% 
% within 
Biopsy 
3.9% 63.3% 33.0% 
Class 4 
Count 16 10 26 
% within SES 61.5% 38.5% 100.0% 
% within 
Biopsy 
31.4% 20.4% 26.0% 
Class 5 
Count 33 8 41 
% within SES 80.5% 19.5% 100.0% 
% within 
Biopsy 
64.7% 16.3% 41.0% 
Total 
Count 51 49 100 
% within SES 51.0% 49.0% 100.0% 
% within 
Biopsy 
100.0% 100.0% 100.0% 
 
Among 100 women,  33%  of women belongs to class 3, 26% belongs to class 4 
and 41% belongs to class 5. CIN lesions more common in lower socio-
economic group. 
In this study 64.7% CIN lesions belongs to class 5 socio-economic group, 
31.4% CIN lesions belongs to class 4 socio-economic group and 3.9% of CIN 
lesions belongs to class 3 socio-economic group. 
  
 
 
 
Table: 4 
Socio-Economic Status 
 
 
 
 
 
 
 
 
 
 
 
 
PARITY 
Table: 5 
 
Parity 
 
Biopsy 
Total Significant(P) 
CIN Cervicitis 
Nulli 
Count 0 1 1 
0.630 
% within Parity .0% 100.0% 100.0% 
% within Biopsy .0% 2.0% 1.0% 
1 
Count 0 1 1 
% within Parity .0% 100.0% 100.0% 
% within Biopsy .0% 2.0% 1.0% 
2 
Count 26 27 53 
% within Parity 49.1% 50.9% 100.0% 
% within Biopsy 51.0% 55.1% 53.0% 
3 
Count 17 13 30 
% within Parity 56.7% 43.3% 100.0% 
% within Biopsy 33.3% 26.5% 30.0% 
>= 4 
Count 8 7 15 
% within Parity 53.3% 46.7% 100.0% 
% within Biopsy 15.7% 14.3% 15.0% 
Total 
Count 51 49 100 
% within Parity 51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
Among 100 women ,1% was nullipara, 1% was primipara, 53% were 
belonging to para2, 30% were belonging to para3  and 15% were belonging to 
para4 and above. 
 
 Among this CIN incidence was 51% in para 2,  33.3% in para 3, 15.7% in para 
4 and above. Among para 3 in 30 cases incidence was 56.7%. Among  para 4 
and above in 15 cases incidence was 53.3%.  
If parity increases occurrence of CIN also increases. In this study also 
increasing parity had increased incidence.   
 
 
 
  
 
 
 
 
Table: 5 
Parity 
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Count 
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LAST CHILD BIRTH 
Table: 6 
 
 
Last Child  Birth 
 
Biopsy 
Total 
 
 
Significant(P) CIN Cervicitis 
Below 5 
Count 11 10 21 
0.913 
% within LCB 52.4% 47.6% 100.0% 
% within Biopsy 21.6% 20.8% 21.2% 
6-10 
Count 15 16 31 
% within LCB 48.4% 51.6% 100.0% 
% within Biopsy 29.4% 33.3% 31.3% 
11-15 
Count 20 16 36 
% within LCB 55.6% 44.4% 100.0% 
% within Biopsy 39.2% 33.3% 36.4% 
Above 15 
Count 5 6 11 
% within LCB 45.5% 54.5% 100.0% 
% within Biopsy 9.8% 12.5% 11.1% 
Total 
Count 51 48 99 
% within LCB 51.5% 48.5% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
Among 99 women, 21.2% were belonging to LCB 5 years group, 31.3% were 
belonging to LCB 6-10 years group, 36.4% were belonging LCB 11-15 years 
group and 11.1% were belonging to LCB more than 15 years group. 
Among those incidence of CIN was 21.6% in less than 5 years duration, 29.4% 
in 6-10 years duration, 39.2% in 11-15 years duration and 9.8% in more than 
15 years duration group. 
In this study, in 11 - 15 years duration group among 36 cases, 20 cases were 
CIN ie 55.6% incidence and more than 15 years duration among 11 cases ,  5 
cases were CIN ie 45.5% incidence .Incidence increases after birth. 
 
 
 
 
 
  
Table: 6 
Last Child Birth 
 
 
Last Child Birth 
Above 15 11-15 6-10 Below 5 
Count 
30 
20 
10 
0 
CIN 
Cervicitis 
SYMPTOMS 
Table: 7 
  
SYMPTOMS 
Biopsy 
Total Significant(P) 
CIN Cervicitis 
Leucorrhoea 
Count 31 32 63 
0.682 
% within 
Symptoms 
49.2% 50.8% 100.0% 
% within Biopsy 60.8% 65.3% 63.0% 
Low 
Abdominal 
Pain 
Count 13 12 25 
% within 
Symptoms 
52.0% 48.0% 100.0% 
% within Biopsy 25.5% 24.5% 25.0% 
Men Dis 
Count 5 2 7 
% within 
Symptoms 
71.4% 28.6% 100.0% 
% within Biopsy 9.8% 4.1% 7.0% 
Screening 
Count 2 3 5 
% within 
Symptoms 
40.0% 60.0% 100.0% 
% within Biopsy 3.9% 6.1% 5.0% 
Total 
Count 51 49 100 
% within 
Symptoms 
51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
 
Among 100 women, in symptoms wise 63% had come with symptom of 
Leucorrhoea, 25% had came with symptom of lower abdomen pain, 7% had 
menstrual disturbances, 5% came for screening for cervical cancer. 
 
Among those CIN incidence was 60.8% in Leucorrhoea group, 25.5% in lower 
abdomen pain group, 9.8% in menstrual disturbances group, 3.9% in screening 
group. 
In this study more cases belongs to Leucorrhoea group. 
  
 
 
 
 
 
  
 
 
 
Table: 7 
Symptoms 
Screening Men Dis Low Abd Pain Leucorroea 
Count 
40 
30 
20 
10 
0 
CIN 
Cervicitis 
EXAMINATION FINDINGS 
Table: 8 
 
 
 
Speculum  Examination 
 
Biopsy 
Total 
 
Signinficant(P) CIN Cervicitis 
Ectopy 
Count 32 29 61 
 
0.436 
% within S/E 52.5% 47.5% 100.0% 
% within Biopsy 62.7% 59.2% 61.0% 
Normal 
Count 19 20 39 
% within S/E 48.7% 51.3% 100.0% 
% within Biopsy 37.3% 40.8% 39.0% 
Total 
Count 51 49 100 
% within S/E 51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 
 
Among 100 women, 61% of women had ectopy on per speculum examination 
findings and normal in 39% of patients. 
 
Among 100 women, CIN incidence was 62.7% in ectopy group and 37.3% in 
normal group. 
 
  
 
 
 
 
Table: 8 
Speculum Examination 
 
Normal Ectopy 
Count 
34 
32 
30 
28 
26 
24 
22 
20 
18 
16 
CIN 
Cervicitis 
COLPOSCOPY 
Table: 9 
 
 
 
Colposcopy 
 
Biopsy 
Total 
 
Significant(P) CIN 1 
CIN 
2/3 
Cervicitis 
High 
grade 
lesion 
Count 1 11 3 15 
0.000 
% within 
Colposcopy 
6.7% 73.3% 20.0% 100.0% 
% within 
Biopsy 
2.5% 100.0% 6.1% 15.0% 
Low grade 
lesion 
Count 36 0 7 43 
% within 
Colposcopy 
83.7% .0% 16.3% 100.0% 
% within 
Biopsy 
90.0% .0% 14.3% 43.0% 
Normal 
study 
Count 3 0 39 42 
% within 
Colposcopy 
7.1% .0% 92.9% 100.0% 
% within 
Biopsy 
7.5% .0% 79.6% 42.0% 
Total 
Count 40 11 49 100 
% within 
Colposcopy 
40.0% 11.0% 49.0% 100.0% 
% within 
Biopsy 
100.0% 100.0% 100.0% 100.0% 
 
 
Among 100 women, 15% cases had high grade lesion, 43% case had low grade 
lesion and 42% had normal study. 
 
Among high grade lesions group, one case that is 6.7% had CIN 1 , 73.3% had 
CIN2/3 and 3cases i.e., 20% had cervicitis.  
 
Among low grade lesions group, 83.7% had CIN1 and 16.3% had cervicitis. 
 
Among normal study group, 7.1% had CIN1 and 92.9% had cervicitis.  
 
 
 
 
 
 
 
  
 
 
 
Table: 9 
Colposcopy 
 
 
Normal study Low grade lesion High grade lesion 
Count 
50 
40 
30 
20 
10 
0 
CIN 1 
CIN 2/3 
Cervicitis 
SENSITIVITY AND SPECIFICITY OF COLPOSCOPY 
 
Table: 10 
 
 
Correct estimation by Colposcopy = 87% 
 
Under estimation by Colposcopy = 10% 
 
Over estimation by Colposcopy = 3%  
 
 
True Positive = 48 
 
False Positive = 10 
 
True Negative = 39 
 
False Negative = 3 
 
 
Colposcopy 
Biopsy 
Total Significant(P) 
CIN Cervicitis 
Positive 
Count 48 10 58 
0.000 
% within 
Colposcopy 
82.8% 17.2% 100.0% 
% within Biopsy 94.1% 20.4% 58.0% 
Negative 
Count 3 39 42 
% within 
Colposcopy 
7.1% 92.9% 100.0% 
% within Biopsy 5.9% 79.6% 42.0% 
Total 
Count 51 49 100 
% within 
Colposcopy 
51.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 
 Sensitivity =  True Positive       × 100 
  True positive + False Negative 
 
       = 48  × 100 = 94.1% 
  48+3 
       
Specificity =  True Negative      × 100 
  True Negative + False Positive 
 
       = 39  × 100 = 79.6% 
  39+10 
 
 
Positive Predictive Value =  True Positive     × 100 
    True Positive + False Positive 
 
                = 48  × 100 = 82.8% 
                     48+10 
 
 
Negative Predictive Value =  True Negative    × 100 
    True Negative + False Negative 
 
                = 39  × 100 = 92.9% 
                      39+3 
 
Accuracy                     = True Positive + True Negative    × 100 
      N 
       
          = 48+39 × 100 = 87% 
                100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table: 10 
 
 
Sensitivity and Specificity of Colposcopy 
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PAP SMEAR 
Table: 11 
Pap smear 
Biopsy 
Total 
Significa
nt(P) CIN 1 CIN 2/3 Cervicitis 
ASCUS 
Count 4 1 5 10 
0.000 
% within PAP 40.0% 10.0% 50.0% 100.0% 
% within Biopsy 10.0% 9.1% 10.2% 10.0% 
HSIL 
Count 1 7 0 8 
% within PAP 12.5% 87.5% .0% 100.0% 
% within Biopsy 2.5% 63.6% .0% 8.0% 
LSIL 
Count 31 2 1 34 
% within PAP 91.2% 5.9% 2.9% 100.0% 
% within Biopsy 77.5% 18.2% 2.0% 34.0% 
NIL 
Count 1 0 43 44 
% within PAP 2.3% .0% 97.7% 100.0% 
% within Biopsy 2.5% .0% 87.8% 44.0% 
US 
Count 3 1 0 4 
% within PAP 75.0% 25.0% .0% 100.0% 
% within Biopsy 7.5% 9.1% .0% 4.0% 
Total 
Count 40 11 49 100 
% within PAP 40.0% 11.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 100.0% 
 
Among 100 women ,10% had ASCUS, 8% had HSIL, 34% had LSIL, 44% 
had NIL and 4% had unsatisfactory reports. 
Among ASCUS group, 40% had CIN1 lesion, 10% had CIN2/3 lesion and 
50% had cervicitis. 
Among HSIL group, 12.5% had CIN1 lesion and 87.5% had CIN2/3 lesion. 
None had cervicitis. 
Among LSIL group , 91.2% had CIN1 lesion, 5.9% had CIN2/3 lesion and 
2.9% had cervicitis. 
Among NIL group , 2.3% had CIN1 lesion, none had CIN2/3 lesion and 97.7% 
had cervicitis. 
Among US group , 75% had CIN1 lesion, 25% had CIN2/3 lesion. None had 
cervicitis. 
 
 
 
 
 
 
 
  
 
Table: 11 
 
 
PAP Smear 
 
 
US NIEL LSIL HSIL ASCUS 
Count 
50 
40 
30 
20 
10 
0 
CIN 1 
CIN 2/3 
Cervicitis 
SENSITIVITY AND SPECIFICITY OF PAP SMEAR 
 
Table: 12 
 
 
Pap smear 
Biopsy 
Total Significant(P) 
CIN Cervicitis 
Positive 
Count 46 6 52 
0.000 
% within PAP 88.5% 11.5% 100.0% 
% within 
Biopsy 
90.2% 12.2% 52.% 
Negative 
Count 5 43 48 
% within PAP 10.4% 89.6% 100.0% 
% within 
Biopsy 
9.8% 87.8% 48% 
Total 
Count 51 49 96 
% within PAP 51% 49% 100.0% 
% within 
Biopsy 
100.0% 100.0% 100.0% 
  
Correct estimation by Pap smear = 89% 
 
Under estimation by Pap smear = 6% 
 
Over estimation by Pap smear = 5%  
 
 
True Positive = 46 
 
False Positive = 6 
 
True Negative = 43 
 
False Negative = 5 
 
 
Sensitivity =  True Positive       × 100 
  True positive + False Negative 
   
        = 46  × 100 = 90.2% 
      46+5 
Specificity  =  True Negative      × 100 
   True Negative + False Positive 
 
       
   = 43  × 100 = 87.8% 
      43+6 
 
 
Positive Predictive Value =  True Positive     × 100 
    True Positive + False Positive 
 
                = 46  × 100 = 88.5% 
                     46+6 
 
 
Negative Predictive Value =  True Negative    × 100 
    True Negative + False Negative 
 
                = 43  × 100 = 89.6% 
                      43+5 
 
Accuracy                     = True Positive + True Negative    × 100 
      N 
       
          = 46+43 × 100 = 89% 
                100 
 
 
 
LIQUID BASED CYTOLOGY 
Table: 13 
 
Liquid Based Cytology 
 Biopsy 
Total Significant 
CIN I 
CNN 
II/III 
Cervicitis 
LBC 
ASCUS 
Count 1 0 0 1 
0.000 
% within LBC 100.0% 0.0% 0.0% 100.0% 
% within Biopsy 2.5% 0.0% 0.0% 1.0% 
HSIL 
Count 1 9 0 10 
% within LBC 10% 90.0% 0.0% 100.0% 
% within Biopsy 2.5% 81.8% .0% 10.0% 
LSIL 
Count 36 2 1 39 
% within LBC 92.3% 5.1% 2.6% 100.0% 
% within Biopsy 90.0% 18.2% 2.0% 39.0% 
NIL 
Count 0 0 48 48 
% within LBC 0.0% 0.0% 100.0% 100.0% 
% within Biopsy 0.0% 0.0% 98.0% 48.0% 
US 
Count 2 0 0 2 
% within LBC 100.0% 0.0% 0.0% 100.0% 
% within Biopsy 5.0% 0.0% 0.0% 2.0% 
Total 
Count 40 11 49 100 
% within LBC 40.0% 11.0% 49.0% 100.0% 
% within Biopsy 100.0% 100.0% 100.0% 100.0% 
 
Among 100 women , 1% had ASCUS result , 10% belongs to HSIL group, 
39% belongs to LSIL group and 2% had unsatisfactory result.  
Among ASCUS group 100% had CIN I lesion. Among HSIL group , 10% had 
CIN I lesion and 90% had CIN II/III lesions. 
Among LSIL group , 90% had CIN I lesions , 18.2% had CIN II/III lesions and 
2% had cervicitis. 
Among NIL group 90% had cervicitis. Among unsatisfactory group 100% had 
CIN I lesions.  
 
  
 
 
 
Table: 13 
Liquid Based Cytology 
 
 
 
US NIEL LSIL HSIL ASCUS 
Count 
60 
50 
40 
30 
20 
10 
0 
CIN 1 
CIN II/III 
CERVICITIS 
SENSITIVITY AND SPECIFICITY OF LIQUID BASED CYTOLOGY 
 
Table: 14 
 
Liquid Based Cytology 
Biopsy 
Total Signifigant(P) 
CIN Cervicitis 
LBC 
Positive 
Count 49 1 50 
0.000 
% within LBC 98% 2% 100% 
% within Biopsy 96.1% 2.0% 50% 
Negative 
Count 2 48 50 
% within LBC 4% 96% 100% 
% within Biopsy 3.9% 98% 50% 
Total 
Count 51 49 100 
% within LBC 51% 49% 100% 
% within Biopsy 100% 100% 100% 
 
Correct estimation by Pap smear = 97% 
 
Under estimation by Pap smear = 1% 
 
Over estimation by Pap smear = 2%  
 
True Positive = 49 
 
False Positive = 1 
 
True Negative = 48 
 
False Negative = 2 
 
Sensitivity =  True Positive       × 100 
  True positive + False Negative 
 
    = 49  × 100 = 96.1% 
      49+2 
 
Specificity  =  True Negative      × 100 
   True Negative + False Positive 
 
       
   = 48  × 100 = 98% 
      48+1 
 
 
Positive Predictive Value =  True Positive     × 100 
    True Positive + False Positive 
 
                = 49  × 100 = 98% 
                     49+1 
 
 
 
Negative Predictive Value =  True Negative    × 100 
    True Negative + False Negative 
 
                = 48  × 100 = 96% 
                      48+2 
 
Accuracy                     = True Positive + True Negative    × 100 
      N 
       
          = 49+48 × 100 = 97% 
    100 
ABSTRACT 
Table: 15 
Test 
True 
Positive 
False 
Positive 
True 
Negative 
False 
Negative 
Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
Accuracy 
(%) 
Colposcopy 48 10 39 3 94.1 79.6 82.8 92.9 87 
Pap Smear 46 6 43 5 90.2 87.8 88.5 89.6 89 
Liquid 
Based 
Cytology 
49 1 48 2 96.1 98 98 96 97 
 
 
 
 
 
 
 
  
 
 
 
Table: 15 
Efficacy of Colposcopy, Pap Smear and LBC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CIN 
Cervicitis 
DISCUSSION 
Cervical cancer is the second most common cancer in developing 
countries. It is a preventable condition because it is associated with long 
precancerous duration making it amenable to screening and treatment. In this 
study, screening was done in 100 women in reproductive age groups with the 
complaints of lower abdominal pain, white discharge, menstrual irregularities. 
Most of the women have ectopy of the cervix and some have normal appearing 
cervix. 
Regarding age distribution high incidence of CIN was found among 30 – 
45 years of age group that is 86.2% of CIN lesions of all age groups. 
According to Kushtagi and Fernands study, the prevalence of CIN was higher 
in women over 30 years.(17) In Vaidhya’s study CIN was more prevalent in 
the age group of more than 35 years.(34)  
Duration of marriage and sexual exposure had a distinct role in genesis 
of CIN.  
In this study, the incidence of CIN was 60.8% among women were 
married for more than 15 yaers. Kushtagi et al., had demonstrated the severity 
of underlying CIN increased with the duration of marriage and sexual 
exposure.(17)  
Increase incidence of CIN is found in multiparous women, in this study 
parity 3 and above have more incidence of CIN lesions i.e., 56.7% in para 3 
group, 53.3% in para 4 or more group. Similar study was done by Shalini et al., 
showed that the mean parity was 4.2 in patients with invasive cancer.(30) 
Kushtagi and Fernands showed that the prevalence was higher in parity of 
more than two(17) and Vaidhya ‘s study also showed more cases of CIN were 
found with parity more than 4.(34) This is due to hormonal and nutritional 
changes occur in pregnancy also due to immunosuppression in pregnancy and 
cervical trauma during vaginal delivery (Becker et al., and Adadevon et al.,(2) 
Socio-economic status plays an important role in the development of 
CIN lesions. In this study, increased incidence of CIN was found in class 5 
socio-economic status group. i.e., 64,7%. Vaidhya’s study also showed 
definitive role of socio-economic status in the development of dysplasia, i.e., 
80% of CIN I and 50% of CIN II were from lower income group.(34) Poor 
hygiene, poor standard of living, multiple sexual partners and early exposure to 
sexual life are the factors associated with both lower income groups and 
cervical dysplasias. 
In this study, 60.8% of women with leucorrhoea had CIN lesions. 
Leucorrhoea plays an important role in the development of CIN. Vaidhya et 
al., also proved the above relation with leucorrhoea by 24% of vaginal 
discharge.(34) 
Regarding the cervical appearances by clinical examination, the most 
common finding is cervical ectopy, where the columnar epithelium replaces the 
squamous epithelium. Ectopy was seen 61% women, among them 52.5% had 
lesions. 
Among 100 women who underwent Colposcopy, 15% cases had high 
grade lesions, 43% cases had low grade lesions and 42% had normal study. In 
high grade lesion group, only 73.3% had CIN 2/3 findings. In low grade lesion 
group , only 83.7% had CIN 1 lesion. In normal study group , 92.9% had 
cervicitis.  
In this study correct estimation of Colposcopy was 87%, the sensitivity 
was 94.1% and the specificity was 79.6%. The positive predictive value of this 
test was 82.8% and the negative predictive value of this test was 92.9%.  
Sensitivity and Specificity of Colposcopy by various authors 
Author Sensitivity (%) Specificity (%) 
Pimple SA et al., 58 – 74.7 57.5 – 92.9 
Olaniyan B (Meta 
analysis) 
87 – 99 26 – 87 
Divya Hegde et al., 70.8 95 
Shuchiconsul et al., 94.7 48.3 
Sukhpreet L: Singh et 
al., 
95 63.5 
Present Study 94.1 79.6 
 
  Divya Hegde et al., study showed that the sensitivity was 70.8%, the 
specificity was 95%, PPV was 62.9%, NPV was 96.5%.(7) 
The meta analysis study by Olaniyan B et al., showed that there was 
high correlation between the Colposcopy and biopsy, the accuracy was 89%. 
The present study also had the accuracy rate of 87%.(23) 
The Colposcopy is the best screening tool because it had low false 
negative rate i.e., 3% and high accuracy rate of 87% which is well correlated 
with biopsy reports. 
In Pap smear study, among 10 women , 10% had ASCUS, 8% had 
HSIL, 34% had LSIL, 44% had NIL and 4% had unsatisfactory reports.  
In ASCUS group , 40% had CIN 1 lesion, 10% had CIN 2 lesions and 
50% had cervicitis . In HSIL group, 87.5% had CIN 2/3 lesions. In LSIL 
group, 91.2% had CIN 1 lesion. In NIL group , 97.7% had cervicitis.  
In the present study , Pap smear had sensitivity rate of 90.2%. The 
specificity was 87.8% and test of accuracy was 89%.  
Author Sensitivity (%) Specificity (%) 
Donald Angstetra et al., 87 -88.6 56.4 – 84.7 
Pimple SA et al., 57.4 99.4 
Sherwani RK et al., 53.7 50 
Matto Sinho de Castro Ferraz 
Mda G et al., 
81.8 85.2 
Hussain T et al., 83 82 
Longatto Filho A et al 59 97 
Divya Hegde et al., 83 98 
Present study 90.2 87.8 
 
The specificity and sensitivity of the present study was correlated with 
Divya Hegde et al., study.(7) 
The Pap smear had high sensitivity, specificity and accuracy rate. The 
reports are well correlated with biopsy reports. So the Pap smear also the best 
screening tool. 
In LBC study, among 100 women , 1% had ASCUS, 10% had HSIL, 
39% had LSIL, 48% had NIL and 2% had unsatisfactory reports.  
In ASCUS group , that one case showed CIN 1 result. In HSIL group , 
90% had CIN 2/3 lesions. In LSIL group , 92.3% had CIN 1 lesion. In NIL 
group all cases had cervicitis.  
 The present study revealed good correlation between LBC and Biopsy 
reports. It had high sensitivity rate of 96.1% and specificity of 98%. The PPV 
was 98%, NPV was 96% and accuracy rate was 97%.  
Author Sensitivity (%) Specificity (%) 
Donald Angstetra et al., 86.6 – 89.1 53.8 – 83.1 
Sherwani RK et al., 97.6 50 
Matto Sinho de Castro 
Ferraz Mda G et al., 
75.3 86.4 
Hussain T et al., 92 76 
B.M. Van Hemel et al 68.3 – 89.4 91.4 – 92.8 
Present Study 96.1 98 
 
Sherwani RK et al., and Hussein T et al., reported that the sensitivity 
was 97.6% and 92% respectively and this result was correlated with the present 
study results.(31)  
The specificity by B.M. VanHemel’s study showed 92.8% and this result 
was in accordance with the present study.(35)    
In this study, LBC is having higher sensitivity and specificity and 
accuracy rate than colposcopy and Pap smear. The sensitivity and specificity of 
combined Colposcopy and pap smear is almost equal to LBC results. Since 
LBC is more expensive, in our settings we can use the combined Colposcopy 
and Pap smear for the cervical cancer screening. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
The present study was a prospective study conducted at ISO and KGH, 
Chennai in the Department of Obstetrics and Gynecology during the period 
January 2011 to November 2012. The study was conducted in 100 women who 
fulfilled the selection criteria and they were randomly selected from 
Gynecology OP. after getting informed consent from all women Colposcopy, 
Pap smear, Liquid based cytology and Cervical biopsy were done. All the 
results were tabulated and analyzed. 
To summarize, 
1. Majority of CIN lesions occurred i.e., 83% in the age group of 30-45 
years. 
2. High incidence of CIN lesions seen in early marriage i.e., 74% in less 
than 19 years (age at marriage). 
3. High incidence of CIN lesions occurred in long duration of sexual 
exposure i.e., 60.8% (more than 15 years duration). 
4. Majority of CIN lesions occurred in class 5 Socio-economic status i.e., 
41%. 
5. The incidence of CIN was high among high parity people i.e., more than 
50% in Para 3 and above group. 
6. Among 100 women , high incidence of CIN lesions i.e., 47% found in 
LCB more than 11 years group. 
7. In symptoms wise high incidence of CIN i.e., 60.8% present in 
leucorrhoea group. 
8. Among 100 women , 61% had ectopic findings on examination.  
9. Colposcopy had high sensitivity of 94.1% and specificity of 79.6%. The 
PPV was 82.8%, NPV was 92.9% and the accuracy rate of 87%. 
10. In this study  based on the results, Colposcopy can be used as the best 
screening tool. 
11. Pap smear showed high sensitivity of 90.2%, specificity of 87.8%, PPV 
of 88.5% , NPV of 89.6% and accuracy rate of 89%. So this is also an 
effective screening method. 
The study concluded that LBC had more sensitivity and specificity than 
Colposcopy and Pap smear i.e., the sensitivity was 96.1%, the specificity was 
98%, the PPV was 98%,  the NPV was 96% and the Accuracy was 97%. Of 
all the three LBC showed the best results. 
In this study, LBC is having higher sensitivity and specificity and 
accuracy rate than colposcopy and Pap smear. The sensitivity and specificity of 
combined Colposcopy and pap smear is almost equal to LBC results. Since 
LBC is more expensive, in our settings we can use the combined Colposcopy 
and Pap smear for the cervical cancer screening. 
 
 
                            CONCLUSION 
Early diagnosis and treatment is the best tool for the prevention cancer 
cervix. Cancer cervix has long precancerous course and it makes amenable to 
screening and treatment.  
This study concluded that accuracy, sensitivity and specificity of LBC 
was higher than the Pap smear and Colposcopy, but it is more expensive. It is 
not used routinely a screening procedure in low resource settings i.e., in 
developing and under developed countries.  
Colposcopy had higher sensitivity and requires single visit for screening 
and treatment. Pap smears require frequent visits for getting reports and further 
treatment. Colposcopy  is used for both screening and treatment.  
In this study Pap smear had more specificity rate when compared with 
Colposcopy. But it had more unsatisfactory rates and need further tests and 
results compared with Colposcopy.   
Colposcopy and Pap smear both are  available in all government settings 
and frequently used as the screening procedures. VIA and VILI are used in all 
health camps.  
All health care providers are trained well in VIA and VILI. They 
screened in all women and referred the positive cases to higher institutions. 
Both Colposcopy and Pap smear combined results showed best sensitivity and 
specificity. They are complementary to one another, so both of them  can be 
used as the best screening tools. 
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PROFORMA 
 
Serial Number :                                                                                    Name :  
OP Number      :                                                                                    Age     : 
Income               : 
  
I. COMPLAINTS 
 
1.    White discharge PV 
                   - Duration 
                   -Quantity 
                    -Colour 
                    -Pruritus 
                   - foul smell 
                        2.    Menstrual disturbances 
                                         -Regular or Irregular 
                                         -Duration and amount 
                                          - Associated Pain 
                                          - Post coital bleeding 
                                          - Inter menstrual  bleeding 
                         3. Lower abdomen 
                          4. Urinary symptoms 
                          5.  Bowel Symptoms 
                           6.  Others 
 
II PERSONAL HISTORY 
                  Diet 
                  Hygiene 
III MENSTRUAL HISTORY 
Age  at menarche 
Cycles 
LMP 
 
IV. MARTIAL HISTORY  
                         .Age 
                          .Duration 
V. OBSTETRIC HISTORY 
                        .PLA 
                         .LCB 
VI. GENERAL EXAMINATION 
                           Built                                                                    thyroid 
                           Anemia                                                              Breast 
                           Pedal edema                                                     BP 
                            Lymphadenopathy                                           PR 
                            CVS                                                                       RS 
VII. PER ABDOMEN 
VIII. LOCAL EXAMINATION OF GENITALIA  
                             
  IX. SPECULUM EXAMINATION  
                          .Cervix 
                           .Vagina 
X.  PAPSMEAR 
XI.   COLPOSCOPIC EXAMINATION 
                    .Normal saline 
                     .Green filter 
                     . Acetic Acid 
                      .Lugol’s Iodine 
XII.  COLPOSCOPIC FINDINGS 
               Normal TZ. 
                Abnormal Acetowhite. 
                 Iodine Negative. 
                Others   
                               Ectopy 
                              Metaplasia. 
XIII. PER VAGINAL EXAMINATION. 
Xiv. PER RECTAL EXAMINATION 
XV.   BIOPSY. 
 
 
 
MASTER CHART 
Name Age 
OPN
O 
Ag
e-
Me
n 
Du
r - 
ma
r 
Age-
mar 
SE
S Parity 
L
C
B Symptoms S/E Colposcopy PAP LBC Biopsy 
Dhilsathbegam 42 28301 14 25 17 5 P3L3 
1
4 Leucorrhoea  Ectopy  
Low grade 
lesion LSIL LSIL CIN-1 
Mallika 40 30481 17 21 19 5 P4L4 
1
5 Leucorrhoea Ectopy 
High grade 
lesion LSIL LSIL CIN-2 
Vani 34 30479 13 17 17 4 P4L4 6 Leucorrhoea Ectopy 
High grade 
lesion HSIL HSIL CIN-2 
Annipesant 28 30295 15 8 20 4 P3L3 4 Leucorrhoea Ectopy 
High grade 
lesion HSIL HSIL CIN-2 
Selvi 36 10379 11 13 23 3 P2L2 
1
0 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Poongodi 36 25853 11 19 17 5 P2L2 
1
5 Low AbdPain Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Valli 35 30475 14 18 17 4 P4L2 
1
3 Screening Ectopy 
Low grade 
lesion NIL NIL Cervicitis 
Jabeenabegam 27 29355 14 6 21 5 P2L2 1 Low AbdPain Normal 
Normal 
study NIL NIL Cervicitis 
Usharani 42 19098 12 22 20 5 P4L4 
1
7 Low AbdPain Normal 
High grade 
lesion HSIL HSIL CIN-2 
Renuga 40 29903 14 23 17 3 P4L3 
1
7 Low AbdPain Ectopy 
High grade 
lesion NIL NIL Cervicitis 
Amudha 35 3586 15 19 16 5 P2L2 
1
4 Low AbdPain Ectopy 
High grade 
lesion HSIL HSIL CIN-2 
Saritha 30 10313 13 13 17 4 P3L2 
1
0 Leucorrhoea Normal 
Normal 
study NIL LSIL CIN-1 
Rajam 42 1360 12 26 16 5 P2L2A1 
2
0 Low AbdPain Ectopy 
High grade 
lesion HSIL HSIL CIN-1 
Sulochana 42 315 15 24 18 3 P3L2 
2
0 Low AbdPain Ectopy 
Normal 
study NIL NIL Cervicitis 
Sasikala 30 3594 12 7 23 4 P2L2 3 Men Dis Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Vasuki 33 16127 13 16 17 5 P2L2 
1
1 Low AbdPain Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Chitra 37 32872 14 20 17 5 P2L2 
1
7 Leucorrhoea Ectopy 
High grade 
lesion HSIL HSIL CIN-2 
Roja 42 5947 15 23 19 4 P4L4 
1
2 Leucorrhoea Normal 
High grade 
lesion HSIL HSIL CIN-2 
Devi 26 36873 14 6 20 3 P2L2 4 Leucorrhoea Ectopy Metaplasia 
ASC
US NIEL Cervicitis 
Devi 28 8301 13 12 16 4 P2L2 
1
0 Leucorrhoea Ectopy 
High grade 
lesion NIL NIL Cervicitis 
Saraswathi 42 6514 12 24 18 4 P2L2 
2
0 Low AbdPain Normal 
High grade 
lesion LSIL HSIL CIN-2 
Malarvizhi 34 1787 13 13 21 4 P2L1 9 Leucorrhoea Normal 
Low grade 
lesion NIL NIL Cervicitis 
Rani 43 7662 13 26 17 3 P3L0 
2
0 Leucorrhoea Normal 
Low grade 
lesion 
ASC
US NIL Cervicitis 
Nageshwari 30 7437 13 12 18 5 P2L2 
1
0 Leucorrhoea Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Gnanasoundari 39 4971 14 23 16 5 P5L5 
1
3 Men Dis Normal 
High grade 
lesion 
ASC
US LSIL CIN-2 
Loganayaki 40 5954 13 24 16 3 P7L3 
1
3 Leucorrhoea Normal Metaplasia NIL NIL Cervicitis 
Kalaivani 32 5173 13 13 19 4 P3L3 
1
0 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Gowri 35 8255 13 19 16 3 P2L2 
1
2 Leucorrhoea Ectopy Metaplasia NIL NIL Cervicitis 
Kumari 37 19454 14 21 18 5 P3L2 
1
2 Low AbdPain Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Devi 28 3772 13 11 17 3 P3L3 8 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
Dhanalakshmi 38 6936 14 21 17 3 P4L4 
1
0 Low AbdPain Ectopy Metaplasia NIL NIL Cervicitis 
Anjalai 28 10443 13 11 17 5 P4L4 6 Leucorrhoea Ectopy 
Normal 
study LSIL LSIL CIN-1 
Jayanthi 30 8875 12 15 15 5 P2L2 5 Low AbdPain Ectopy 
Low grade 
lesion US LSIL CIN-1 
Nagajothi 26 6761 13 8 18 3 P2L2 3 Leucorrhoea Ectopy 
High grade 
lesion NIL NIL Cervicitis 
 Zamuruth 30 7682 13 13 17 4 P3L3 8 Leucorrhoea Ectopy 
Low grade 
lesion NIL NIL Cervicitis 
Thenmozhi 36 11322 12 20 16 5 P2L2 
1
3 Leucorrhoea Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Valarmathi 30 11343 12 11 19 4 P2L2 8 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Mallika 37 11013 13 20 17 4 P2L2 
1
5 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Sudha 30 10340 12 6 24 5 P2L2A1 6 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
Leelavathi 40 4744 13 20 20 3 P1L1 
1
9 Low AbdPain Normal 
Normal 
study NIL NIL Cervicitis 
Andal 38 10199 12 15 23 3 P3L3 5 Leucorrhoea Normal 
Low grade 
lesion NIL NIL Cervicitis 
Lakshmi 32 6653 13 15 17 5 P3L3 3 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Banumathi 30 11010 13 12 18 5 P2L2 2 Leucorrhoea Ectopy 
Normal 
study LSIL LSIL CIN-1 
Valli 36 9945 14 15 21 3 P2L2 
1
2 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
Dhanalakshmi 30 8915 13 13 17 5 P4L4 5 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL Cervicitis 
Maheswari 28 7371 12 12 16 4 P3L3A1 4 Low AbdPain Normal 
Low grade 
lesion US 
ASC
US CIN-1 
Jothilakshmi 27 11277 13 10 17 5 P2L2 8 Leucorrhoea Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Noornisha 38 10336 12 23 15 5 P4L4 
1
3 Men Dis Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Loganayaki 42 10304 13 25 17 4 P4L4 
1
2 Leucorrhoea Normal 
High grade 
lesion HSIL HSIL CIN-3 
Baragath 41 11023 13 21 20 3 P4L4 
1
2 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Kiruba 37 13181 12 20 17 5 P2L2A1 
1
4 Low AbdPain Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Revathi 29 11038 14 12 17 5 P2L2 6 Leucorrhoea Ectopy 
Low grade 
lesion 
ASC
US LSIL CIN-1 
Guna 36 13485 12 18 18 5 P3L3 
1
2 Men Dis Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Baby 33 12912 13 14 19 3 P2L2A2 
1
0 Screening Ectopy 
Normal 
study NIL NIL Cervicitis 
Suseela 36 12791 14 16 20 4 P2L2 
1
2 Screening Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Deepa 27 11005 13 7 20 5 P2L2 3 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Suguna 42 13616 12 20 22 3 P3L3 
1
5 Low AbdPain Ectopy 
Normal 
study NIL NIL Cervicitis 
Kalavathi 40 14122 13 20 20 3 P4L4 
1
3 Low AbdPain Ectopy 
Normal 
study NIL NIL Cervicitis 
Valli 37 17510 14 19 18 3 P2L2 
1
0 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Meenatchi 28 28175 12 10 18 3 P2L2A1 2 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Nadhiya 28 13832 13 10 18 3 P2L2A1 3 Leucorrhoea Normal Metaplasia NIL NIL Cervicitis 
Mahalakshmi 33 33627 12 16 17 3 P2L2A1 
1
0 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
Umamaheswari 37 24761 13 21 16 3 P3L3 
1
3 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
Jayakodi 30 30844 12 12 18 5 P3L3 5 Leucorrhoea Ectopy 
Low grade 
lesion 
ASC
US LSIL CIN-1 
Amudha 35 5433 13 12 23 4 P2L2 7 Leucorrhoea Ectopy 
High grade 
lesion US HSIL CIN-2 
Subbulakshmi 33 15297 12 10 23 4 P2L2A1 7 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Samsathbegum 40 108 14 20 20 5 P3L3 
1
2 Low AbdPain Ectopy 
Normal 
study NIL NIL Cervicitis 
Latha 40 14247 13 19 21 5 P2L2 
1
6 Low AbdPain Normal 
Normal 
study NIL NIL Cervicitis 
Mariammal 30 188 14 13 17 3 P2L2 9 Leucorrhoea Normal Metaplasia NIL NIL Cervicitis 
Gowri 32 15812 11 12 20 5 P2L2A1 8 Men Dis Normal 
Normal 
study NIL NIL Cervicitis 
Punitha 24 13210 13 7 17 5 P2L2A1 3 Men Dis Ectopy 
Low grade 
lesion 
ASC
US LSIL CIN-1 
  
 
 
 
Kamali 42 10343 15 25 17 4 P2L2A1 
1
5 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Glory 40 1339 12 20 20 5 P2L2 
1
5 Leucorrhoea Normal 
Low grade 
lesion LSIL US CIN-1 
Lakshmi 35 13360 11 16 19 4 P2L2 
1
3 Leucorrhoea Normal 
Normal 
study 
ASC
US NIL Cervicitis 
Sairabanu 33 37260 13 17 16 5 P3L3 
1
1 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Jayalakshmi 34 30658 12 16 18 5 P3L3 6 Low AbdPain Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Kamatchi 38 14710 11 21 17 3 P3L3 6 Leucorrhoea Ectopy Metaplasia NIL NIL Cervicitis 
Ponni 32 11238 12 15 17 3 P3L3 9 Leucorrhoea Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Geetha 34 16069 13 18 16 5 P2L2A1 9 Leucorrhoea Ectopy 
Low grade 
lesion US US CIN-1 
Parimala 27 7865 12 5 22 5 P2L2 3 Screening Ectopy 
Normal 
study NIL NIL Cervicitis 
Allimalar 29 9764 14 10 19 3 P2L2 7 Low AbdPain Ectopy 
Normal 
study NIL NIL Cervicitis 
Gunasundari 41 15088 12 16 25 4 P2L2A1 
1
0 Leucorrhoea Ectopy 
Low grade 
lesion 
ASC
US LSIL CIN-1 
Padma 38 13342 11 17 21 3 P3L3 8 Low AbdPain Normal 
Normal 
study NIL NIL Cervicitis 
Geetha 32 37150 13 13 19 5 P2L2A1 5 Leucorrhoea Ectopy Metaplasia NIL NIL Cervicitis 
Kalaivani 30 16211 12 14 16 5 P3L3 6 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Parvathi 35 16544 11 18 17 4 P3L3 5 Leucorrhoea Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Jeeva 42 13919 12 24 18 3 P2L3 
1
8 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Renuga 38 14219 13 21 17 4 P3L3 
1
3 Low AbdPain Normal Metaplasia NIL NIL Cervicitis 
Pushpa 37 16778 14 20 17 3 P2L2 
1
3 Men Dis Normal 
Normal 
study NIL NIL Cervicitis 
Sathya 37 16630 12 21 16 5 P3L3 
1
0 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Vahithabegum 31 17044 13 13 18 3 Nulli 
 
Leucorroea Ectopy 
Low grade 
lesion 
ASC
US NIL Cervicitis 
Rahamath 40 1118 11 20 20 5 P2L2 
1
5 Screening Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Selvi 30 17193 12 13 17 3 P2L2 5 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Gunavathi 41 15535 13 22 19 5 P3L3 
1
5 Low AbdPain Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Kamala 27 15961 12 8 19 4 P3L3 2 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Usha 37 14128 14 19 18 3 P3L3 
1
1 Leucorrhoea Ectopy 
Normal 
study NIL NIL Cervicitis 
Jayachitra 38 23248 11 20 18 5 P2L2 
1
7 Leucorrhoea Ectopy 
Low grade 
lesion LSIL LSIL CIN-1 
Saradhammal 38 22873 13 21 17 4 P3L3A1 
1
5 Low AbdPain Normal 
Low grade 
lesion LSIL LSIL CIN-1 
Vijayalakshmi 39 487 12 22 17 3 P2L2A1 
1
4 Leucorrhoea Ectopy 
Normal 
study 
ASC
US NIL Cervicitis 
Rajaveni 42 19012 12 23 19 4 P2L2 
1
5 Leucorrhoea Normal 
Normal 
study NIL NIL Cervicitis 
  
KEY TO MASTER CHART  
 
CIN  Cervical Intra epithelial Neoplasia 
HSIL  High grade Squamous Intra epithelial Lesion 
LSIL  Low grade Squamous Intra epithelial Lesion 
NIL  Negative for Intra epithelial Lesion 
US  Unsatisfactory 
LBC             Liquid Based Cytology 
ASCUS Atypical Squamous Cells of Undetermined Signifcance 
LCB  Last Child Birth 
SES              Socio-Economic Status 
Age-men      Age at menarche 
Age-mar       Age at marriage 
Dur-mar        Duration of marriage 
S/E   Speculum Examination 
 
 
